Small nucleolar RNA signatures of lung tumor-initiating cells

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Mannoor, Kaiissar ^a   Shen, Jun ^a   Liao, Jipei ^a   Liu, Zhenqiu ^b   Jiang, Feng ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CASPASE 3; CD133 ANTIGEN; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; SMALL NUCLEOLAR RNA; SMALL NUCLEOLAR RNA 18; SMALL NUCLEOLAR RNA 3; SMALL NUCLEOLAR RNA 42; SMALL NUCLEOLAR RNA 61; SMALL NUCLEOLAR RNA 62; SMALL NUCLEOLAR RNA D110; SMALL NUCLEOLAR RNA D116-26; SMALL NUCLEOLAR RNA D14E; SMALL NUCLEOLAR RNA D1C; SMALL NUCLEOLAR RNA D33; SMALL NUCLEOLAR RNA D34; SMALL NUCLEOLAR RNA D36C; SMALL NUCLEOLAR RNA D38B; SMALL NUCLEOLAR RNA D44; SMALL NUCLEOLAR RNA D55; SMALL NUCLEOLAR RNA D66; SMALL NUCLEOLAR RNA D73B; SMALL NUCLEOLAR RNA D76; SMALL NUCLEOLAR RNA D78; SMALL NUCLEOLAR RNA D83B; SMALL NUCLEOLAR RNA D88A; SMALL NUCLEOLAR RNA D96A; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; SMALL INTERFERING RNA; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER STEM CELL; CANCER TISSUE; CELL ASSAY; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INITIATING CELL; TUMOR XENOGRAFT; UPREGULATION; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMAN; LUNG NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SCID MOUSE; SIGNAL TRANSDUCTION; SURVIVAL;

AGED; ANIMALS; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; RNA, SMALL INTERFERING; RNA, SMALL NUCLEOLAR; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901276714     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-104     Document Type: Article

References (26)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29. 10.3322/caac.21208, 24399786.
2. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
3. O'Connor ML, Xiang D, Shigdar S, Macdonald J, Li Y, Wang T, Pu C, Wang Z, Qiao L, Duan W. Cancer stem cells: a contentious hypothesis now moving forward. Cancer Lett 2014, 344:180-187. 10.1016/j.canlet.2013.11.012, 24333726.
4. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15:504-514. 10.1038/sj.cdd.4402283, 18049477.
5. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009, 7:330-338. 10.1158/1541-7786.MCR-08-0393, 19276181.
6. Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA, Jiang F. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:327-337. 10.1158/1055-9965.EPI-09-0865, 3544173, 20142235.
7. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 2010, 90:234-244. 10.1038/labinvest.2009.127, 3552330, 20010854.
8. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006, 15:R17-R29. 10.1093/hmg/ddl046, 16651366.
9. Negrini M, Ferracin M, Sabbioni S, Croce CM. MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007, 120:1833-1840. 10.1242/jcs.03450, 17515481.
10. Mannoor K, Liao J, Jiang F. Small nucleolar RNAs in cancer. Biochim Biophys Acta 1826, 2012:121-128.
11. Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, Wang XW. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 2009, 50:472-480. 10.1002/hep.22989, 2721019, 19585654.
12. Garzia L, Andolfo I, Cusanelli E, Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L, Esposito S, Gargiulo S, Fattet S, Donofrio V, Cinalli G, Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD, Iolascon A, Zollo M. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One 2009, 4:e4998. 10.1371/journal.pone.0004998, 2656623, 19308264.
13. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009, 8:e6816.
14. Mei YP, Liao JP, Shen J, Yu L, Liu BL, Liu L, Li RY, Ji L, Dorsey SG, Jiang ZR, Katz RL, Wang JY, Jiang F. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 2012, 22:2794-2804.
15. Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, Liu Z, Jiang F. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 2010, 9:198. 10.1186/1476-4598-9-198, 2919450, 20663213.
16. Lafontaine DL, Tollervey D. Birth of the snoRNPs: the evolution of the modification-guide snoRNAs. Trends Biochem Sci 1998, 23:383-388. 10.1016/S0968-0004(98)01260-2, 9810226.
17. Weinstein LB, Steitz JA. Guided tours: from precursor snoRNA to functional snoRNP. Curr Opin Cell Biol 1999, 11:378-384. 10.1016/S0955-0674(99)80053-2, 10395551.
18. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006, 311:230-232. 10.1126/science.1118265, 16357227.
19. Runte M, Varon R, Horn D, Horsthemke B, Buiting K. Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome. Hum Genet 2005, 116:228-230. 10.1007/s00439-004-1219-2, 15565282.
20. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 2009, 106:16281-16286. 10.1073/pnas.0905653106, 2741477, 19805294.
21. Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg 2009, 36:446-453. 10.1016/j.ejcts.2009.03.063, 19464919.
22. Tu LC, Foltz G, Lin E, Hood L, Tian Q. Targeting stem cells-clinical implications for cancer therapy. Curr Stem Cell Res Ther 2009, 4:147-153. 10.2174/157488809788167373, 3034385, 19442199.
23. de Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR, Fessler E, van den Bergh SP, Rodermond H, Dekker E, van der Loos CM, Pals ST, van de Vijver MJ, Versteeg R, Richel DJ, Vermeulen L, Medema JP. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011, 9:476-485. 10.1016/j.stem.2011.10.008, 22056143.
24. Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J, Mannoor K, Deepak J, Donahue JM, Stass SA, Xing L, Jiang F. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 2014, 27:1181-1189.
25. Xing L, Todd NW, Yu L, Fang H, Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010, 8:1157-1164.
26. Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H, Shen J, Zhao RY, Caraway NP, Katz RL, Stass SA, Jiang F. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 2007, 16:7901-7906.